Viatris: Is It A Credible Turnaround Or Overly Optimistic 2030 Plan?

As you know, Viatris Inc. ( VTRS ) has just outlined a pretty ambitious long-term strategy through to 2030. The aim is to transform its base business into a much more durable, higher-marginI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges b ...